Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (111-120 of 545) with videos related to

Pageof 55
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Why does a higher response rate to chemotherapy correlate poorly with improved survival?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 24th annual meeting of the Society of Gynecologic Oncologists, February 7-10, 1993M Markman
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current status of intraperitoneal therapy for ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?M Markman
Cleveland Clinic Journal of Medicine|March 24, 1998
Cancer and the mind: separating fact from fictionM Markman
Cleveland Clinic Journal of Medicine|May 26, 1998
Cancer information and the Internet: benefits and risksM Markman
Seminars in Oncology|June 20, 1998
Intraperitoneal therapy of ovarian cancerM Markman
Medical and Pediatric Oncology|January 1, 1982
Metastatic adenocarcinoma of unknown primary site: analysis of 245 patients seen at The Johns Hopkins Hospital from 1965--1979M Markman
Seminars in Oncology|August 1, 1997
Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancerM Markman
Gynecologic Oncology|May 24, 2001
Prolonged symptom-free survival in a patient with persistent primary peritoneal carcinoma and a rising CA-125: a note of cautionM Markman
Pageof 55

Showing results (111-120 of 545) with videos related to

Sort By:
Pageof 55
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Why does a higher response rate to chemotherapy correlate poorly with improved survival?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 24th annual meeting of the Society of Gynecologic Oncologists, February 7-10, 1993M Markman
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current status of intraperitoneal therapy for ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?M Markman
Cleveland Clinic Journal of Medicine|March 24, 1998
Cancer and the mind: separating fact from fictionM Markman
Cleveland Clinic Journal of Medicine|May 26, 1998
Cancer information and the Internet: benefits and risksM Markman
Seminars in Oncology|June 20, 1998
Intraperitoneal therapy of ovarian cancerM Markman
Medical and Pediatric Oncology|January 1, 1982
Metastatic adenocarcinoma of unknown primary site: analysis of 245 patients seen at The Johns Hopkins Hospital from 1965--1979M Markman
Seminars in Oncology|August 1, 1997
Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancerM Markman
Gynecologic Oncology|May 24, 2001
Prolonged symptom-free survival in a patient with persistent primary peritoneal carcinoma and a rising CA-125: a note of cautionM Markman
Pageof 55